疏肝和胃散治疗汁反流性胃炎的临床研究.pdfVIP

  • 45
  • 0
  • 约4.03万字
  • 约 35页
  • 2016-03-24 发布于贵州
  • 举报

疏肝和胃散治疗汁反流性胃炎的临床研究.pdf

疏肝和胃散治疗汁反流性胃炎的临床研究

Clinical Study on Shuganheweisan in Treating Bile Reflux Gastritis Specia1ity:Internal medicine of traditional Chinese medicine Author:Yang guoxiang Tutor:Professor Liu weiming Abstract Objective: To observe the clinical curative effect of shuganhewei san in treating bile reflux gastritis (BRG). Methods: The randomized controlled method was adopted. The selected cases were randomly divided into two groups:treatment groups and contorl groups.30 patients in treatment group were treated with Shuganheweisan, and patients in control group were treated with Danweikang Capsule. Treatment: All patients were treated for four weeks. The changes of primary clinical symptoms and signs in all cases were observed and given evaluation after treatment. Result: The curative effect of the therapy group were obviously better than that of the contorl group(P<0.01orP<0.05). Conclusions: Shuganheweisan is a effective formular to cure BRG. No significant toxic and side effect and adverse reactions are observed. The mechanism of the formular is probably to promote gastritis emptying ,harmonize stomach-duodenal,anti-gastritis, anti-ulcer and protect the stomach. This finding authenticated the clinical utility and feasibility of Shuganheweisan. Then deep study and approach are deserved . Key word Shuganheweisan;Bile Reflux Gastritis; Clinical research 目 录 引 言 1 临床研究 2 一、病例选择标准 2 (一)诊断标准 2 (二)纳入病例标准 3 (三)排除病例标准 3 (四)剔除病例标准 3 二、一般资料 3 (一)性别分布比较 4 (二)年龄分布比较 4 (三)治疗前两组患者胆汁反流程度比较 4 (四)治疗前两组症状积分比较 4 三、治疗方法 5 实验组 5 四、观察指标 5 (一)安全性观察指标 5 (二)疗效观察指标 5 五、疗效评价标准 6 (一)临床症状疗效评定标准

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档